SEC Form D · filed May 12, 2023
Comanche Biopharma Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (22)
Brendan S. Bulik-Sullivan · Concord, MADirectorMuzammil S. Mansuri · Concord, MADirectorClive S. Meanwell · Concord, MADirectorArthur S. Levin · Concord, MADirectorPaul S. Antinori · Cocoa, FLExecAllison S. August · Concord, MAExecAnn S. Taylor · Concord, MADirectorAllyson S. Felix · Concord, MADirectorKetan S. Patel · Concord, MADirectorMichael S. Young · Chicago, ILExecThomas S. Johnson · Concord, MAExec · DirectorArthur S. Levin · Concord, MADirectorBrendan S. Bulik-Sullivan · Concord, MADirectorMuzammil S. Mansuri · Concord, MADirectorPaul S. Antinori · Concord, MAExecAllison S. August · Concord, MAExecAnn S. Taylor · Concord, MADirectorClive S. Meanwell · Concord, MADirectorAllyson S. Felix · Concord, MADirectorKetan S. Patel · Concord, MADirectorMichael S. Young · Chicago, ILExecThomas S. Johnson · Concord, MAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗